A new mouse study by researchers at the University of California (UC), San Diego, School of Medicine reveals that an enzyme ...

EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first ...

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

Researchers from the University of Michigan have developed a way of detecting circulating tumor cells in the bloodstream of ...

An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new study.

Immuneering Corporation (NASDAQ:IMRX) on Tuesday announced plans to add three new combination arms for its Phase 2a program ...

Researchers at UC San Diego have discovered that the enzyme MICAL2 accelerates tumor growth in pancreatic cancer by ...

Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies ...

Pancreatic ductal adenocarcinoma remains a challenge to treat due to its complex biology and resistance mechanisms.

The Whipple procedure, which removes part of the pancreas, intestine and gallbladder, is the standard for pancreatic cancer.

Cancer is an umbrella term used to characterize the abnormal growth of cells in different organs and tissues. Specific cancer ...

Pancreatic cancer kills 50,000 people each year, according to the National Cancer Institute, and there are few effective ...